oyj

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

July 21, 2025 03:30 ET  | Source: Orion Oyj ORION CORPORATION PRESS RELEASE 21 JULY 2025 at 10:30 EEST           Darolutamide…

5 days ago

Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs

June 17, 2025 02:00 ET  | Source: Orion Oyj ORION CORPORATION PRESS RELEASE 17 JUNE 2025 at 9.00 EEST         Orion…

1 month ago